Extended-Release Buprenorphine Treatment for Opioid Use Disorder
We offer extended-release buprenorphine treatment for individuals living with Opioid Use Disorder (OUD). Long-acting injectable buprenorphine is an effective, evidence-based option for patients who prefer an alternative to taking daily medication.
There are two FDA-approved forms of injectable buprenorphine available at our practice: Sublocade® and Brixadi®. Both medications are administered as subcutaneous injections and provide continuous medication delivery to help reduce cravings and prevent withdrawal symptoms.
Sublocade® is given as a once-monthly injection
Brixadi® is available in weekly or monthly formulations
Extended-release buprenorphine can be an excellent option for patients seeking:
Consistent medication levels
Improved treatment adherence
Reduced daily medication burden
Greater privacy and convenience
Our clinicians will work closely with each patient to determine whether long-acting injectable buprenorphine is the right choice as part of a comprehensive, individualized treatment plan for opioid addiction recovery.
Information from manufacturer